Hidradenitis Suppurativa (HS) is a prevalent and debilitating disease predominating in women and minorities. Despite its prevalence and morbidity, the biology of HS is poorly understood, thus limiting the development of effective therapies. Rigorous investigation of cutaneous dysbiosis (abnormal microbial colonization of skin) and immune dysregulation associated with HS is urgently needed to understand their roles in HS pathogenesis, and to guide the development of novel therapeutic approaches for this devastating disease.

Dr. Naik is trained both in dermatology and in clinical investigative methods. She is an emerging leader in immune-mediated skin disease research. Her research team's primary goals are to elucidate the mechanisms underlying HS, and to better understand the impact of HS on patients. Dr. Naik also provides specialty care for patients suffering from HS in the context of the UCSF Hidradenitis Suppurativa Clinic which she established.